Zepto Life Technology’s mould infection panel obtains FDA breakthrough designation June 5, 2026 Zepto Life’s FungiFlex mould panel is designed to identify 14 clinically important mould species based on cell free fungal DNA detected in plasma. Read More »
Tandem wins CE mark for automated insulin delivery in type 2 diabetes, pregnancy June 5, 2026 Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received expanded CE mark for its automated insulin delivery (AID) systems. Read More »